Janney Montgomery Scott LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 14,697 shares of the company’s stock, valued at approximately $479,000.
Other hedge funds have also made changes to their positions in the company. Texas Permanent School Fund grew its holdings in Bath & Body Works by 2.1% during the 3rd quarter. Texas Permanent School Fund now owns 32,172 shares of the company’s stock worth $1,049,000 after acquiring an additional 671 shares during the last quarter. Raymond James & Associates grew its holdings in Bath & Body Works by 49.0% during the 3rd quarter. Raymond James & Associates now owns 17,136 shares of the company’s stock worth $559,000 after acquiring an additional 5,639 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in Bath & Body Works by 37.9% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 27,034 shares of the company’s stock worth $881,000 after acquiring an additional 7,437 shares during the last quarter. Xponance Inc. grew its holdings in Bath & Body Works by 7.1% during the 3rd quarter. Xponance Inc. now owns 26,038 shares of the company’s stock worth $849,000 after acquiring an additional 1,723 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new stake in Bath & Body Works during the 3rd quarter worth about $288,000. Institutional investors and hedge funds own 96.34% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the stock. Robert W. Baird raised their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a research note on Thursday, November 17th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $40.00 to $43.00 in a report on Tuesday, January 3rd. Citigroup boosted their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock a “buy” rating in a report on Friday, November 18th. Piper Sandler lifted their price objective on shares of Bath & Body Works from $50.00 to $52.00 in a research report on Tuesday, January 3rd. Finally, Bank of America boosted their target price on shares of Bath & Body Works from $48.00 to $50.00 in a research report on Thursday, November 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $51.52.
Bath & Body Works Trading Up 1.7 %
Bath & Body Works (NYSE:BBWI – Get Rating) last announced its quarterly earnings data on Wednesday, November 16th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.21. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Bath & Body Works had a negative return on equity of 40.90% and a net margin of 12.48%. As a group, analysts predict that Bath & Body Works, Inc. will post 3.15 earnings per share for the current year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 2nd. Investors of record on Friday, November 18th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, November 17th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.78%. Bath & Body Works’s dividend payout ratio is 20.83%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Get a free copy of the StockNews.com research report on Bath & Body Works (BBWI)
- CVS Health is Growing into an Integrated Healthcare Organization
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Get Rating).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.